Anti-neovascular therapy by use of liposomes targeted to angiogenic vessels

Journal of Liposome Research

Volumn 13, Issue 1, 2003, Pages 25-27

  Oku, N ^a   Asai, T ^a   Watanabe, K ^a   Kuromi, K ^a   Ogino, K ^b   Taki, T ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CYTOTOXIC AGENT; DOXORUBICIN; DRUG CARRIER; LIPOSOME; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS ISLET CELL TUMOR; PHAGE DISPLAY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; LIPOSOMES; MICE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PEPTIDE LIBRARY;

EID: 0037242163     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-120017485     Document Type: Conference Paper

References (3)

1. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60:1878-1886.
2. Kurohane K, Tominaga A, Sato K, North JR, Namba Y, Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett 2001; 167:49-56.
3. Oku N, Asai T, Watanabe K, Kuromi K, Nagatsuka M, Kurohane K, Kikkawa H, Ogino K, Tanaka M, Ishikawa D, Tsukada H, Momose M, Nakayama J, Taki T. Anti-neovascular therapy using novel peptides homing to angiogenic vessels. Oncogene. In press.